OBJECTIVES: Willingness to participate in HIV-1 vaccine trials and associated factors were investigated in a sample of 2670 Royal Thai Army conscripted recruits. METHODS: Self administered questionnaires were used. Data were collected during the final visit of a longitudinal cohort study of HIV-1 epidemiology. Cross sectional analysis of data from this visit was performed. RESULTS: 32% of the respondents reported they would "definitely" join an HIV-1 vaccine trial. Greater willingness was associated with perceived risk of HIV-1 infection and a desire to help Thai society, although tangible incentives and intentions to reduce condom use in a vaccine trial also were associated with increased willingness. Concerns about physical harm and anticipated social pressure from family not to join were the most substantial impediments to willingness. Concerns about "social harm" (for example, participation would give appearance of having AIDS virus, a partner might refuse sex) also appeared to inhibit interest in joining trials and approached significance. CONCLUSIONS: Willingness to participate was somewhat greater than in other investigations of non-injection drug user (IDU) cohorts in Thailand, with fewer concerns expressed about physical harm. Motivations appear to involve tradeoffs among perceived risk, anticipated social pressure, altruism, and tangible rewards. The absence of significant problems associated with vaccine trials to date, along with the presence of educational interventions in the study may help explain the lower level of concerns here relative to other Thai studies.
OBJECTIVES: Willingness to participate in HIV-1 vaccine trials and associated factors were investigated in a sample of 2670 Royal Thai Army conscripted recruits. METHODS: Self administered questionnaires were used. Data were collected during the final visit of a longitudinal cohort study of HIV-1 epidemiology. Cross sectional analysis of data from this visit was performed. RESULTS: 32% of the respondents reported they would "definitely" join an HIV-1 vaccine trial. Greater willingness was associated with perceived risk of HIV-1 infection and a desire to help Thai society, although tangible incentives and intentions to reduce condom use in a vaccine trial also were associated with increased willingness. Concerns about physical harm and anticipated social pressure from family not to join were the most substantial impediments to willingness. Concerns about "social harm" (for example, participation would give appearance of having AIDS virus, a partner might refuse sex) also appeared to inhibit interest in joining trials and approached significance. CONCLUSIONS: Willingness to participate was somewhat greater than in other investigations of non-injection drug user (IDU) cohorts in Thailand, with fewer concerns expressed about physical harm. Motivations appear to involve tradeoffs among perceived risk, anticipated social pressure, altruism, and tangible rewards. The absence of significant problems associated with vaccine trials to date, along with the presence of educational interventions in the study may help explain the lower level of concerns here relative to other Thai studies.
Authors: K M MacQueen; S Vanichseni; D Kitayaporn; L S Lin; A Buavirat; T Naiwatanakul; S Raktham; P Mock; W L Heyward; D C Des Jarlais; K Choopanya; T D Mastro Journal: J Acquir Immune Defic Syndr Date: 1999-07-01 Impact factor: 3.731
Authors: D L Hom; J L Johnson; P Mugyenyi; R Byaruhanga; C Kityo; A Louglin; G M Svilar; M Vjecha; R D Mugerwa; J J Ellner Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1997-08-15
Authors: D D Celentano; K C Bond; C M Lyles; S Eiumtrakul; V F Go; C Beyrer; C na Chiangmai; K E Nelson; C Khamboonruang; C Vaddhanaphuti Journal: Arch Intern Med Date: 2000-02-28
Authors: K E Nelson; D D Celentano; S Eiumtrakol; D R Hoover; C Beyrer; S Suprasert; S Kuntolbutra; C Khamboonruang Journal: N Engl J Med Date: 1996-08-01 Impact factor: 91.245
Authors: D D Celentano; C Beyrer; C Natpratan; S Eiumtrakul; L Sussman; P O Renzullo; C Khamboonruang; K E Nelson Journal: AIDS Date: 1995-09 Impact factor: 4.177
Authors: D D Celentano; K E Nelson; S Suprasert; S Eiumtrakul; N Galai; S Kuntolbutra; N Wright; C Theetranont Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1995-12-01
Authors: Edith A M Tarimo; Anna Thorson; Muhammad Bakari; Joachim Mwami; Eric Sandström; Asli Kulane Journal: Glob Health Action Date: 2009-08-07 Impact factor: 2.640
Authors: Maria Flavia Gazzinelli; Lucas Lobato; Leonardo Matoso; Renato Avila; Rita de Cassia Marques; Ami Shah Brown; Rodrigo Correa-Oliveira; Jeffrey M Bethony; David J Diemert Journal: PLoS Negl Trop Dis Date: 2010-07-20